Vaccination may prevent lingering immune harm after acute viral illness
A mouse study from Pompeu Fabra University found that recovering from an acute viral infection can leave the immune system less responsive for an extended period. Animals that had been vaccinated before infection avoided this prolonged immune impairment and retained stronger responses to later challenges. The findings, published in Cell Death & Disease, suggest vaccination offers benefits beyond direct protection against the initial pathogen.
Researchers at Pompeu Fabra University studied mice that had cleared an acute viral infection. Even after the virus was controlled, the animals’ spleens showed fibrosis and disrupted immune-cell arrangement, which hindered T-cell activation and left them less able to respond to new immune challenges.
In the same model, mice vaccinated before infection did not develop this lasting immune disruption. The work, published in Cell Death & Disease, suggests that vaccination’s value may include preserving immune function after recovery, not only blocking illness from the initial virus.
If similar processes occur in humans, people recovering from acute viral illnesses might face temporary or prolonged weaker immune responses, potentially affecting vulnerability to later infections or vaccine responses. Clinical follow-up and vaccination planning could be informed by such findings, though mouse results cannot be directly translated. This may matter for patients, clinicians, and public-health planning.